Daiken Biomedical Co (TPE:7780) LT-Debt-to-Total-Asset: 0.00 (As of Dec. 2025)


TPE:7780 Daiken Biomedical Co Ltd TPE:7780
23 GF Score
Price NT$18.00
! 6 Warning Signs
View Full Analysis

What is Daiken Biomedical Co LT-Debt-to-Total-Asset?

Daiken Biomedical Co TPE:7780 -1.91% 23 LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus rates TPE:7780 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Daiken Biomedical Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.00.

Daiken Biomedical Co's long-term debt to total assets ratio increased from Dec. 2024 (0.00) to Dec. 2025 (0.00). It may suggest that Daiken Biomedical Co is progressively becoming more dependent on debt to grow their business.

Daiken Biomedical Co  (TPE:7780) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Daiken Biomedical Co LT-Debt-to-Total-Asset Related Terms

Daiken Biomedical Co LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Daiken Biomedical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiken Biomedical Co LT-Debt-to-Total-Asset Chart

Daiken Biomedical Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
0.12 0.07 0.00 0.00

Daiken Biomedical Co Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TPE:7780
23GF Score
Daiken Biomedical Co Ltd TPE:7780
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiken Biomedical Co LT-Debt-to-Total-Asset Calculation

Daiken Biomedical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=15.178/5912.651
=0.00

Daiken Biomedical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )/Total Assets (Q: Dec. 2025 )
=15.178/5912.651
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Daiken Biomedical Co (TPE:7780) has a LT-Debt-to-Total-Asset of 0.00 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Daiken Biomedical Co and its competitors.
Is Daiken Biomedical Co's LT-Debt-to-Total-Asset too high?
Daiken Biomedical Co's current LT-Debt-to-Total-Asset is 0.00. Overall, Daiken Biomedical Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Daiken Biomedical Co's LT-Debt-to-Total-Asset compare to KHC and GIS?
Daiken Biomedical Co's LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Consumer Packaged Goods company?
A good LT-Debt-to-Total-Asset depends on the Consumer Packaged Goods industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Daiken Biomedical Co and its competitors. Daiken Biomedical Co's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Biomedical Co stock overvalued right now?
Daiken Biomedical Co (TPE:7780) has a current LT-Debt-to-Total-Asset of 0.00. The current LT-Debt-to-Total-Asset is 0.00. Daiken Biomedical Co's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Daiken Biomedical Co (TPE:7780), the current LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Daiken Biomedical Co Business Description

Address Roosevelt Road, 12th Floor, No. 37, Section 3, Daan District, Taipei, TWN
Daiken Biomedical Co Ltd is engaged in Research, development, and sales of health food. Its products include fish oil capsules, collagen powder, collagen drinks, natto capsules, and mint leaf capsules. The companies reportable operating segment consists solely of the e-commerce division.
23GF Score

Get the complete analysis for TPE:7780

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$18.00
Price